Enterococcal bacteremia in children: Clinical Significance of vancomycin resistance

被引:0
|
作者
Jo, Kyo Jin [1 ]
Lee, Hyeon Seo [2 ]
Lee, Narae [1 ]
Byun, Shin Yun [1 ]
Chang, Chulhun [3 ]
Park, Su Eun [1 ]
机构
[1] Pusan Natl Univ, Yangsan Hosp, Sch Med, Dept Pediat, Yangsan, South Korea
[2] Pusan Natl Univ, Off Infect Control, Yangsan Hosp, Yangsan, South Korea
[3] Pusan Natl Univ, Sch Med, Dept Lab Med, Yangsan, South Korea
来源
PEDIATRICS AND NEONATOLOGY | 2025年 / 66卷 / 02期
关键词
Bacteremia; Children; Enterococcus; Vancomycin-resistant enterococci; BLOOD-STREAM INFECTIONS; RISK-FACTORS; EPIDEMIOLOGY;
D O I
10.1016/j.pedneo.2024.01.007
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: We aimed to describe the clinical and microbiological characteristics of enterococcal bacteremia, as well as the effect of Enterococcus resistance against vancomycin on clinical outcomes in Korean children. Methods: We retrospectively reviewed the medical records of children diagnosed with enterococci isolated from blood cultures at Pusan National University Children's Hospital between December 2009 and November 2021. Results: In total, 64 patients were enrolled in the study. The median age was 0 years (range 0-15), and 43 (67.2%) patients were male. Enterococcus faecalis (50%) was the most commonly identified bacterial strain. Significant underlying diseases were present in 60 patients (93.8%), and the source of bacteremia was identified in 36 patients (56.3%). Among these, intravascular device was the most common identifiable source. Fifty-six (87.5%) patients had previously received broad-spectrum antibiotics and 54 (84.4%) patients were nosocomial in origin. Twenty-nine (45.3%) strains were resistant to ampicillin, and 16 (25%) strains were resistant to vancomycin. All patients with vancomycin-resistant enterococci (VRE) had underlying disease (P = 0.199), and focus of bacteremia was significantly more frequent in VRE patients (P = 0.014). Of all the patients, after appropriate antibiotic treatment, five (7.8%) patients had recurrent enterococcal bacteremia, and seven (10.9%) patients were diagnosed with bacteremia, defined as other pathogens from blood culture. The 30-day mortality rate was 7.8%. Conclusion: Enterococcal bacteremia in children is usually nosocomial and occurs in children with serious underlying diseases. Because the number of enrolled patients and mortality were small in our study, it is difficult to identify whether the factor that determines prognosis in patients with enterococcal bacteremia is VRE or an underlying disease. Further studies with a large number of patients in a specific group are needed.
引用
收藏
页码:142 / 146
页数:5
相关论文
共 50 条
  • [41] Vancomycin-resistant enterococcal bacteremia:: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis
    Chou, Yen-Yi
    Lin, Te-Yu
    Lin, Jung-Chung
    Wang, Ning-Chi
    Peng, Ming-Yieh
    Chang, Feng-Yee
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2008, 41 (02) : 124 - 129
  • [42] Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review
    Bhavarth S. Shukla
    Timothy P. Gauthier
    Ricardo Correa
    Laura Smith
    Lilian Abbo
    International Journal of Clinical Pharmacy, 2013, 35 : 697 - 703
  • [43] Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review
    Shukla, Bhavarth S.
    Gauthier, Timothy P.
    Correa, Ricardo
    Smith, Laura
    Abbo, Lilian
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 697 - 703
  • [44] Enterococcal bacteremia: Vancomycin resistant (VRE) versus sensitive (VSE) strains.
    Montero, J
    Larkin, J
    Mbaga, I
    Sinnott, J
    Shashy, R
    Ballow, C
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (01) : 14A - 14A
  • [45] Vancomycin resistance factor of Lactobacillus rhamnosus GG in relation to enterococcal vancomycin resistance (van) genes
    Tynkkynen, S
    Singh, KV
    Varmanen, P
    INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 1998, 41 (03) : 195 - 204
  • [46] ENTEROCOCCAL RESISTANCE TO VANCOMYCIN AND RELATED CYCLIC GLYCOPEPTIDE ANTIBIOTICS
    SHLAES, DM
    BINCZEWSKI, B
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (02) : 106 - 110
  • [47] Vancomycin resistance has no influence on outcomes of enterococcal bacteriuria
    Khair, H. N.
    VanTassell, P.
    Henderson, J. P.
    Warren, D. K.
    Marschall, J.
    JOURNAL OF HOSPITAL INFECTION, 2013, 85 (03) : 183 - 188
  • [48] Contemporary Clinical and Molecular Epidemiology of Vancomycin-Resistant Enterococcal Bacteremia: A Prospective Multicenter Cohort Study (VENOUS I)
    Contreras, German A.
    Munita, Jose M.
    Simar, Shelby
    Luterbach, Courtney
    Dinh, An Q.
    Rydell, Kirsten
    Sahasrabhojane, Pranoti, V
    Rios, Rafael
    Diaz, Lorena
    Reyes, Katherine
    Zervos, Marcus
    Misikir, Helina M.
    Sanchez-Petitto, Gabriela
    Liu, Catherine
    Doi, Yohei
    Abbo, Lilian M.
    Shimose, Luis
    Seifert, Harald
    Gudiol, Carlota
    Barberis, Fernanda
    Pedroza, Claudia
    Aitken, Samuel L.
    Shelburne, Samuel A.
    Duin, Davidvan
    Tran, Truc T.
    Hanson, Blake M.
    Arias, Cesar A.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (03):
  • [49] Mortality (M) of vancomycin-susceptible (VSE) versus vancomycin-resistant enterococcal (VRE) bacteremia (B).
    Nimmagadda, AP
    Goetz, MB
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 48 - 48
  • [50] Clinical profile and strain relatedness of recurrent enterococcal bacteremia
    Cheng, AC
    Murdoch, DR
    Harrell, LJ
    Reller, LB
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2005, 37 (09) : 642 - 646